Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance

Nitroxyl donors retain their depressor effects in hypertension

(2013) Jennifer C. Irvine et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Nitroxyl (HNO)

(2013) Hani N. Sabbah et al.   Circulation-Heart Failure

Vasorelaxant and antiaggregatory actions of the nitroxyl donor isopropylamine NONOate are maintained in hypercholesterolemia

(2011) Michelle L. Bullen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Nitrate Therapy

(2011) Thomas Münzel et al.   CIRCULATION

Chronic Administration of the HNO Donor Angeli's Salt Does Not Lead to Tolerance, Cross-Tolerance, or Endothelial Dysfunction: Comparison with GTN and DEA/NO

(2010) Jennifer C. Irvine et al.   ANTIOXIDANTS & REDOX SIGNALING

Nitroxyl (HNO) as a Vasoprotective Signaling Molecule

(2010) Michelle L. Bullen et al.   ANTIOXIDANTS & REDOX SIGNALING

Redox variants of NO (NO· and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms

(2009) Joanne L. Favaloro et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries

(2009) Karen L Andrews et al.   BRITISH JOURNAL OF PHARMACOLOGY

Effects of aspirin, nimesulide, and SC-560 on vasopressin-induced contraction of human gastroepiploic artery and saphenous vein*

(2009) Martin Aldasoro et al.   CRITICAL CARE MEDICINE

The Effects of Nitroxyl (HNO) on Soluble Guanylate Cyclase Activity

(2009) Thomas W. Miller et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Mechanisms Underlying Activation of Soluble Guanylate Cyclase by the Nitroxyl Donor Angeli's Salt

(2009) A. Zeller et al.   MOLECULAR PHARMACOLOGY

Nitroxyl (HNO): the Cinderella of the nitric oxide story

(2008) Jennifer C. Irvine et al.   TRENDS IN PHARMACOLOGICAL SCIENCES